{"disease":{"id":"ranibizumab","name":"ranibizumab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05248334","title":"A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Tianjin Medical University Eye Hospital","has_results":false},{"nct_id":"NCT04062370","title":"Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03054766","title":"Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Beijing Hospital","has_results":false},{"nct_id":"NCT06173245","title":"Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Egyptian Biomedical Research Network","has_results":false},{"nct_id":"NCT05701124","title":"Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Zagazig University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}